Guardion Health Sciences, Inc.

NasdaqCM:GHSI Stock Report

Market Cap: US$7.4m

Guardion Health Sciences Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Guardion Health Sciences.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Personal Products earnings growth23.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper

Sep 22
Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper

Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost

Jun 06
Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost

Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

Apr 10
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward

Feb 06
Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward

Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues

Apr 17
Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues

Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M

Aug 11

Guardion Health closes Activ Nutritional acquisition

Jun 02

Guardion Health initiates GlaucoCetin glaucoma trial

May 03

The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More

Jan 15
The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More

Guardion Health names industry veteran Bret Scholtes as new president and CEO

Dec 28

Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?

Nov 24
Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Guardion Health Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:GHSI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202412-5-4-4N/A
3/31/202412-5-3-3N/A
12/31/2023120-4-4N/A
9/30/20236-14-4-4N/A
6/30/20236-16-5-5N/A
3/31/20239-10-7-7N/A
12/31/202211-16-7-7N/A
9/30/202211-17-8-8N/A
6/30/202211-19-8-8N/A
3/31/20229-27-11-10N/A
12/31/20217-25-11-11N/A
9/30/20215-14-11-11N/A
6/30/20212-13-11-11N/A
3/31/20212-9-9-9N/A
12/31/20202-9-8-8N/A
9/30/20202-9-8-8N/A
6/30/20202-9-8-8N/A
3/31/20201-12-7-7N/A
12/31/20191-11-6-6N/A
9/30/20191-8-5-5N/A
6/30/20191-8-4-4N/A
3/31/20191-7-4-3N/A
12/31/20181-8-4-4N/A
9/30/20181-9-5-5N/A
6/30/20181-9-5-5N/A
3/31/20181-8N/A-4N/A
12/31/20170-6N/A-3N/A
9/30/20170-6N/A-2N/A
6/30/20170-6N/A-2N/A
3/31/20170-6N/A-2N/A
12/31/20160-7N/A-2N/A
9/30/20160-5N/A-2N/A
6/30/20160-6N/A-1N/A
3/31/20160-7N/A-1N/A
12/31/20150-9N/A-1N/A
9/30/20150-8N/A-1N/A
12/31/20140-1N/A-1N/A
12/31/20130-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if GHSI's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if GHSI's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if GHSI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if GHSI's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if GHSI's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GHSI's Return on Equity is forecast to be high in 3 years time


Discover growth companies